Shareholders Equity: The sum of preferred and common equity items.
Achieve Life Sciences, Inc. (ACHV) had Shareholders Equity of $10.68M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.17M |
|
-- |
|
-- |
|
$10.46M |
|
$-10.46M |
|
$0.29M |
|
$-10.17M |
|
$-10.17M |
|
$-10.17M |
|
$-10.17M |
|
$-10.17M |
|
$-10.17M |
|
$-10.46M |
|
$-10.39M |
|
53.38M |
|
53.38M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$31.06M |
|
-- |
|
$2.04M |
|
$33.10M |
|
$11.83M |
|
$9.32M |
|
$10.59M |
|
$22.43M |
|
$10.68M |
|
$8.95M |
|
|
Shareholders Equity |
$10.68M |
53.24M |
|
| Cash Flow Statement Financials | |
$-6.93M |
|
$14.28M |
|
$0.02M |
|
$20.95M |
|
$28.31M |
|
$7.36M |
|
$-0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
0.47 |
|
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-95.22% |
|
-113.63% |
|
-30.71% |
|
-50.84% |
|
$0.20 |
|
$-0.13 |
|
$-0.13 |
|